INTRODUCTION
Genetically based tools for perturbing cellular function are increasingly used to study the contributions of different cell types to development, physiology, and behavior. The utility of these tools depends critically on the cell-type specificity of their expression, and there is considerable demand for targeting methods with greater selectivity than is currently available. In general, selectivity of expression is achieved by using DNA regulatory elements of one or more genes normally expressed by a cell type of interest to drive the expression of a primary transgene, such as Gal4 or Cre; the primary transgene can then activate the expression of secondary transgenes that mediate functional perturbations (Branda and Dymecki, 2004; Venken et al., 2011b; Yizhar et al., 2011) .
Co-opting a gene's full complement of regulatory elements to faithfully target all the cells that express it has been best achieved by inserting a transgene coding sequence into one of its translated exons (Demir and Dickson, 2005; Diao and White, 2012; Taniguchi et al., 2011) . This approach, however, is labor intensive and lacks the convenient modularity of less-precise targeting systems, such as transposon-based systems, in which recombinase-mediated cassette exchange (RMCE) can be used to swap primary transgenes (Gohl et al., 2011) .
A targeting method that combines the simplicity of RMCE with the precision of directly coupled transgene and native gene expression for use with fly lines that carry the engineered transposable element MiMIC (i.e., Minos-mediated integration cassette) was recently described in Drosophila (Venken et al., 2011a) . When a MiMIC insertion is in the 5 0 UTR of the gene of interest, RMCE can be used to replace the MiMIC cassette with an artificial exon encoding a primary transgene, preceded by a universal splice acceptor. The splice acceptor insures inclusion of the transgene coding sequence in the mature message of the native gene, and the transgene's start methionine, rather than the native gene's, directs its translation. Although a similar strategy can be used to introduce artificial exons into MiMIC insertions within coding introns, which are two-and-a-half times more numerous than 5 0 UTR intron insertions (Venken et al., 2011a) , co-translation of these artificial exons produces fusion proteins that will not predictably retain the function of a primary transgene's product. Therefore the MiMIC method's utility for gaining genetic access to cell types of interest is currently limited to genes with MiMIC insertions in 5 0 UTR introns, and most Drosophila genes lack any MiMIC insertion.
To overcome these limitations, we have created an integrated toolkit of artificial exons that capitalize on the ability of the viral T2A peptide to promote the translation of a second protein product from a single transcript Tang et al., 2009) . Incorporation of the T2A sequence permits transcriptional effectors encoded by our artificial exons to be expressed from sites within coding introns and thus extends the ''plug-and-play'' flexibility of the MiMIC system to this important class of intron. We have further extended the capabilities of our toolkit by creating an artificial exon that can be targeted to a coding intron in any gene of interest by using the recently developed Crispr/Cas technology (Gratz et al., 2013) . This allows most genes in the fly genome to serve as gateways to genetically access to the cells that express them.
By analogy to the Trojan horse, we call our artificial exons ''Trojan exons'' because they gain access to cells through their insertion into coding introns and ''release'' transcriptional effectors that render the cells susceptible to exploitation by other transgenes. The palette of Trojan exons presented here includes most of the transcriptional effectors commonly used in the fly and enables the fast and easy creation of driver lines with high-fidelity expression in the pattern of an endogenously expressed gene. Although developed for use in Drosophila, the Trojan exon approach should be readily adaptable for use in other genetic model organisms.
RESULTS

Tools for Creating Gal4 Drivers from MiMIC Lines with Inserts into Coding Introns
We have previously shown that the T2A peptide can effectively promote the expression of a Gal4 transgene in the pattern of a native Drosophila gene of interest when the T2A and Gal4 coding sequences are fused in-frame to the coding sequence of the native gene by homologous recombination . To simplify this procedure for Drosophila genes that contain MiMIC transposons in coding introns, we have adapted the protein-trap vectors previously developed by Venken et al. (2011a) to permit insertion of the T2A-Gal4 sequences directly into the mature message of the native gene by mRNA splicing ( Figure 1A ; Table 1 ). Embryonic injection of such a vector into germline cells expressing FC31 integrase leads to exchange of the T2A-Gal4-containing cassette, thus producing a Gal4 driver line that has an expression pattern corresponding to that of a native gene.
Because approximately 10% of Drosophila genes currently have MiMIC insertions into coding introns, a wide selection of genes is amenable to this technique (Nagarkar-Jaiswal et al., 2015; http://flypush.imgen.bcm.tmc.edu/pscreen/mimic.html). To test its efficacy, we focused on genes of neurobiological interest because of the nervous system's large array of cell types and also because cell-type specific targeting has found its greatest use in mapping neuronal circuits. Two genes of considerable neurobiological interest for which high-fidelity Gal4 lines have been lacking are those encoding the vesicular glutamate transporter (i.e., VGlut; Figure 1B ), and choline acetyltransferase (i.e., Cha; Figure 1C ), which are expressed in neurons that use glutamate and acetylcholine as neurotransmitters, respectively. Both genes contain intronic MiMIC inserts (VGlut MI04979 , phase 2; Cha MI04508 , phase 0) that are common to all splice isoforms of the respective genes, and for both, there are Gal4 driver lines made by other methods (Mahr and Aberle, 2006; Salvaterra and Kitamoto, 2001 ). These lines thus permit the direct comparison of commonly used drivers with those generated by the Trojanmediated conversion of MiMIC (Trojan-MiMIC) technique described here.
Targeting Glutamatergic and Cholinergic Neurons using a Trojan Gal4 Exon Trojan-MiMIC lines were created as described in the Experimental Procedures, with recombinant flies identified directly by Gal4-driven expression of a fluorescent reporter in the G1 generation ( Figure S1A ). Cassette replacement was also later verified by PCR. The VGlut and Cha genes are broadly expressed in the nervous system, so reporter-mediated fluorescence was readily detectable in live larvae, and driver lines could be established within two generations. Both Trojan-MiMIC drivers exhibited expression patterns broadly consistent with the expression of their respective genes (Daniels et al., 2008; Yasuyama et al., 1995) -Gal4 (Table 2 ). The one noted exception to fidelity of expression was a set of neurons in the posterior optic lobe that is clearly labeled by the VGlut MI04979 -Gal4 driver, despite not being readily detected by anti-VGlut antiserum ( Figure S2 ). These neuronal somata, which may simply stain below the detection threshold of the anti-VGlut antibody, are likewise included in the expression pattern of an enhancer-trap line widely used to target glutamatergic neurons, OK371-Gal4 (Mahr and Aberle, 2006) .
For a more detailed assessment of the fidelity of the VGlut MI04979 -Gal4 and Cha MI04508 -Gal4 lines, we examined their expression in three pairs of medial, segmentally repeated neurons in the larval ventral nerve cord (VNC) identifiable by their expression of the Even-skipped protein, Eve (Fujioka et al., 2003) . Two pairs of Eve + neurons, aCC and RP2, are known glutamatergic motor neurons (Vactor et al., 1993) , while the third, pCC, is a putative cholinergic interneuron. Consistent with their neurotransmitter phenotypes, both aCC and RP2 motor neurons are within the expression pattern of the VGlut MI04979 -Gal4 line ( Figures 1B'' ', left, and 1B''''), while only pCC is included in the pattern of the Cha MI04508 -Gal4 line ( Figure 1C ''', left), strongly suggesting that pCC is cholinergic. An existing cholinergic driver, Cha 7.4 -Gal4, which was made using a 7.4-kb genomic fragment located upstream of the Cha coding sequence, also labels the pCC pair, but inconsistently, and often labels the glutamatergic aCC motor neurons (Figures 1C''', right, and 1C'''') . Similarly, OK371-Gal4 fails to express consistently in the glutamatergic motor neurons, often not labeling RP2 ( Figures 1B''' , right, and 1B''''). The two driver lines made using the TrojanMiMIC method thus display a high degree of fidelity when compared with similar drivers made by other methods. The consistent labeling of pCC interneurons by Cha Figure 1D ). We created the GluRIIB
MI03631
-and GluRIIE MI01909 -Gal4 driver lines, which, as expected, expressed Gal4 in all larval bodywall muscles ( Figure 1D' ), though the patterns generated by GluRIIE MI01909 -Gal4 were weaker than those generated by GluRIIB MI03631 -Gal4 and exhibited some variegation. We also examined the expression of the GluRIIB and GluRIIE genes in adult animals, where the subunit composition of glutamate receptors at neuromuscular junctions is largely unknown. While GluRIIB MI03631 -Gal4 does not drive observable reporter expression in any muscle in 1-week-old adults, GluRIIE MI01909 -Gal4 produced a distinct pattern of expression in ventral muscles of the abdomen ( Figure 1D ''). We again observed variegation, sometimes quite pronounced, which has been previously documented for other Gal4 lines (Skora and Spradling, 2010) . However, such variation is the exception, and most Trojan-MiMIC Gal4 insertions yield robust and stable expression patterns.
Efficiency of Generating Trojan-MiMIC Gal4 Lines
We have successfully generated two or more Trojan-MiMIC lines for each of the Trojan Gal4 exons in the three possible reading frames (Table 1 ). The efficiency of cassette exchange using the microinjection protocol ranged from 3% to 33% (i.e., percentage of fertile adults from Trojan-Gal4-injected embryos that yielded Gal4-expressing progeny). Overall, recombinant progeny were identified for 15 of 16 independent MiMIC insertions tested, although for several genes, we could not establish stocks, and in some cases, recombinant animals were poorly viable. While truncation of the endogenous gene product by the introduction of T2A-Gal4 may, in some cases, have created a dominantnegative version of the endogenous protein with deleterious effects, such effects were not consistently observed for all Trojan exons introduced into the same locus. For example, heterozygous Gad1 MI09277 -Gal4 animals were severely impaired, but heterozygous Gad1 MI09277 -p65AD animals were viable and healthy ( Table 1 ), suggesting that the Trojan exons encoding the different transcriptional effectors may be spliced with different efficacies. In any case, our findings suggest that the majority of MiMIC sites in coding introns can be converted into viable Trojan-MiMIC Gal4 lines by microinjection techniques.
In Vivo Generation of Trojan-MiMIC Gal4 Driver Lines
Because microinjection is both expensive and laborious, we also designed a cheaper system for generating Trojan-MiMIC Gal4 flies that relies on simple genetic crosses and that can produce large numbers of recombinants. We created fly lines carrying either single or ''triplet'' Trojan donor constructs (Table 1) , which generate attB-flanked integration cassettes when excised from the genome. The more universally useful triplet donor has three cassettes ( Figure 2A ), each containing a Trojan Gal4 exon in one of the three reading frames. Each Trojan exon is flanked by attB sites and a pair of uniquely compatible lox sites, which are substrates of the Cre recombinase (Livet et al., 2007) . By crossing flies from this triplet donor line to flies with germline expression of both Cre recombinase and FC31 integrase, one can induce Cre-mediated excision and circularization of the three cassettes, which can then be integrated into the attP sites of a MiMIC insertion by FC31 integrase (Bischof et al., 2007) . These Trojan Gal4 vectors lack the Hsp70 pA and are designed to retain a gene's native transcription termination signals (e.g., when microRNA binding sites are present in the 3 0 UTR). For two genes analyzed, we found no detectable differences in the expression patterns obtained with these constructs compared with those obtained with constructs containing the Hsp70 pA. We recommend use of the latter constructs to insure robust transcription termination unless mRNA downregulation is a known or suspected problem.
To test this ''in vivo'' Trojan-MiMIC system, we selected MiMIC insertions in three genes, each of which required a T2A-Gal4 construct in a different reading frame: (1) Guanylyl Cyclase Beta-100B (Gycb100B
MI01568
; ph 2; Figure 2B ), which encodes a subunit of the nitric-oxide-sensitive soluble guanylyl cyclase (Shah and Hyde, 1995) ; (2) Resistant to Dieldrin (Rdl
MI02957
, ph 1; Figure 2C ) which encodes a well-characterized Drosophila GABA-A receptor a-subunit (Buckingham et al., 2005) ; and (3) amontillado (amon MI00899 , ph 0; Figure 2D ), which encodes the Drosophila ortholog of Prohormone Convertase 2, an enzyme critical for the processing of neuropeptides (Wegener et al., 2011) . Gal4 lines were successfully generated for these three genes ( Figure S1B ), confirming that all three Trojan Gal4 constructs of the triplet donor are functional. In addition, all three appeared to be excised from the donor locus and re-integrated into the MiMIC site with similar efficiency, as determined by PCR analysis of all 61 independent exchange events produced in the generation of the Gycb100B MI01568 -Gal4 line ( Figure S3 ). In total, eight exchange events resulted in phase 2 insertions with the robust Gycb100B
MI01568
-Gal4 CNS expression pattern seen in Figure 2B '. Interestingly, nine phase 1 insertions in the opposite direction gave expression patterns that were largely non-neural (data not shown) due to the fortuitous intronic localization of MI01568 in a second gene (i.e., stops) encoded on the opposite strand.
The expression patterns of both the Rdl MI02957 -and amon MI00899 -Gal4 lines conform closely to those reported for the Rdl and amon genes, respectively (Harrison et al., 1996; Wegener et al., 2011) . Rdl MI02957 -Gal4 drives reporter expression broadly in the adult brain, most notably in structures previously identified by antibody staining to express Rdl protein, including the mushroom body lobes, the ellipsoid body, and the antennal lobes ( Figure 2C' ). In addition, expression of a UAS-Rdl-RA transgene (Sá nchez-Soriano and Prokop, 2005) eliminated larval lethality in animals mutant for Rdl (data not shown). Despite some lethality later in development, surviving adults bearing the rescue transgene were fertile and could be propagated as a stable stock, indicating that the Rdl MI02957 -Gal4 expression pattern includes all essential Rdl-expressing neurons. Notably, the expression pattern of the Rdl MI02957 -Gal4 line contrasts to the more restricted patterns produced by two previously published promoter-fusion Rdl-Gal4 lines (Hekmat-Scafe et al., 2010; Yuan et al., 2014) , neither of which exhibited expression in all previously characterized sites of Rdl expression ( Figure S4 ). The Rdl-Gal4 2-2 line, which has a second chromosome transgene insertion and could therefore be readily assayed for its ability to rescue the larval lethality of Rdl mutations, failed to do so (data not shown).
As expected, the amon MI00899 -Gal4 line expression pattern included many neurons with the large somata characteristic of neurosecretory cells (Figure 2D', upper panel) , including a well-known group that express crustacean cardioactive peptide (i.e., CCAP; Figure 2D '', upper panels). This group is likewise present in the expression pattern of a Gal4 line made by P-element transgenesis using a putative amon enhancer element (Rhea et al., 2010 ) (amon-Gal4; Figures 2D' and 2D '', lower panels). However, the latter line has both weaker and sparser expression than amon MI00899 -Gal4 in the nervous system, and, unlike amon MI00899 -Gal4, fails to label the peripheral endocrine cells (i.e., Inka cells) that make the peptide ecdysis triggering hormone (ETH; Figure 3D '''). Evidence for amon gene expression in Inka cells has been ambiguous: amon mRNA is found in embryonic Inka cells by in situ hybridization (Siekhaus and Fuller, 1999) , but larval Inka cells are reported to lack Amon immunoreactivity (Park et al., 2004; Rayburn et al., 2009 ). To determine whether Inka cells express the amon gene, we selectively knocked down its expression using an Inka-cell-specific driver (ETH-Gal4) and UAS-amon-RNAi. We found substantial developmental deficits in ecdysis at all stages of development as is expected for loss of ETH function ( Figure S5 ). This result strongly suggests that Amon protein is present at levels below the threshold of antibody detection and that the amon MI00899 -Gal4 line, but not the amon-Gal4 line, faithfully reports its expression.
Creating Trojan-MiMIC Lines for Combinatorial Expression
It is often necessary to genetically target specific cells based not on their expression of a single gene of interest but on their expression of two such genes (Luan and White, 2007; Pfeiffer et al., 2010; Potter et al., 2010) . To permit such combinatorial targeting, we created Trojan exons for several transgenes other than Gal4 ( Figure 1A ; Table 1 ), including the Gal4 inhibitor, Gal80, which effects a Boolean NOT operation when used in conjunction with Gal4 drivers, and components of the Split Gal4 system (Gal4DBD, dVP16AD, and p65AD), which can be used in combination to perform a Boolean AND operation and identify neurons common to the patterns of expression of two genes. The 3XGal80 Trojan exon (see Experimental Procedures) is designed to express three copies of Gal80, one of which is tagged with epitopes for hemagglutinin (HA) and FLAG and another of which is tagged with EGFP. A VGlut MI04979 -3XGal80 line generated with this construct has the same fidelity of expression as VGlut MI04979 -Gal4, as demonstrated by double labeling with anti-VGlut and anti-GFP antibodies ( Figure 3A) , and effectively subtracts glutamatergic neurons from the expression pattern of the pan-neural elav-Gal4 driver line ( Figure 3B ). Similarly, an amon MI00899 -p65AD line has a neuronal expression pattern that matches that of the previously described amon MI00899 -Gal4 line ( Figure 3C , left), as revealed by using it in conjunction with an elav-Gal4DBD hemidriver, and can be used to target the subpopulation of CCAP-expressing neurons ( Figure 3C , middle), when used in conjunction with a CCAP-Gal4DBD hemidriver. Importantly, restriction of expression can be used to identify and manipulate previously inaccessible subsets of neuropeptidergic neurons. For example, amon nerve cord that express the neuropeptide proctolin (Anderson et al., 1988) , and numerous other central neurons (Figure 3C, right) . In the same way, a Shaw MI01735 -dVP16AD line in conjunction with a Burs-Gal4DBD line isolates a subpopulation of neurons that expresses both the Shaw K + channel and the Burs subunit of the hormone bursicon ( Figure 3D ). Overlap of two expression patterns and a variety of dual manipulations can also be accomplished using orthogonal binary expression systems (Lai and Lee, 2006; Potter et al., 2010) , and to facilitate such applications, we created Trojan exons for the transcriptional activators QF2 and LexA::QFAD (Riabinina et al., 2015) , which drive the expression of transgenes placed downstream of QUAS and LexA op sequences, respectively (Table 1) . We applied these reagents to the question of whether acetylcholine and glutamate are used as neurotransmitters by distinct populations of neurons. While this is thought to be the case, a comprehensive comparison has not been possible with existing tools. Using Cha and found no segmentally reiterated overlap in expression (Figure 3E) , suggesting that specification of the main transmitter systems in the Drosophila nervous system is mutually exclusive. Simultaneous targeting of different cell types can also be used to label or manipulate both upstream and downstream partners within an interacting pair. To demonstrate this application, we made a VGlut MI04979 -LexA::QFAD line to drive expression of LexA op -transgenes in motor neurons and used it together with the previously described GluRIIB MI03631 -Gal4 line to simultaneously label both pre-and post-synaptic elements at the larval neuromuscular junction ( Figure 3F ).
T-GEM: A MiMIC-Independent Application of the Trojan Exon Approach
While the growing collection of MiMIC insertions in Drosophila is an invaluable resource for the implementation of the TrojanMiMIC technique, MiMIC insertions into coding introns are still not available for all fly genes. To make the ''plug-and-play'' versatility of Trojan exons more generally serviceable-both in the fly and potentially in other model organisms-we created a MiMIC-like Trojan Gal4 construct that can be targeted to genomic loci by homologous recombination using the Crispr/ Cas technology (Gratz et al., 2013) . Targeted insertion of this Trojan-Gal4 expression module (T-GEM; Figure 4A ) into an intronic locus generates a Gal4 driver line that can be easily converted by cassette exchange into any other type for which Trojan exons have been created. To demonstrate the use of T-GEM, we targeted its insertion to an intron in the pburs gene, which encodes a subunit of the heterodimeric hormone Bursicon shown to exhibit anti-Pburs immunoreactivity (Luo et al., 2005) (Figures 4B' and 4B'', brackets) . In addition, the pattern includes several other pairs that are not immunoreactive for Pburs but are immunoreactive for Burs, the heterodimeric partner of Pburs (Figures 4B''' and 4B'''') . The observation that Pburs TGEM -Gal4 driven reporter expression coincides with Burs expression in these neurons is consistent with reports that only Burs/Pburs heterodimers have biological activity (Luo et al., 2005) and indicates, as in other cases, that the Trojan exon driver is a more sensitive indicator of gene expression than a corresponding antibody.
DISCUSSION
The Trojan exon tools introduced here permit the rapid production of transgenic fly lines for cell-type-specific manipulation. The advantages of the Trojan exon system include (1) fully modular design using off-the-shelf, exchangeable Trojan constructs; (2) the ease of FC31-mediated cassette exchange after the initial creation of a suitable target site; (3) the availability in Drosophila of thousands of ready-made target sites in the form of MiMIC lines with insertions into coding introns; (4) the ability to create novel intronic target sites using the T-GEM vector, which simultaneously creates a Gal4 driver; and (5) high-fidelity co-expression of transgene and targeted native gene. While genes lacking introns or genes for which the elimination of a single allele is lethal are not amenable to the Trojan exon technique, such genes are not numerous in Drosophila, and special cases, such as essential genes on the X chromosome, can be easily accommodated by the Trojan exon strategy ( Figure S6 ). In cases where the mutagenic nature of Trojan insertions adversely affects viability, we find that different Trojan exons vary in their degree of lethality, and the range of such exons introduced here gives experimenters considerable latitude in making gene-and cell-type-specific reagents.
For the majority of Drosophila genes tested, we found that Trojan exon-generated driver lines duplicated the expression pattern of the native gene with higher fidelity, and detected its expression with greater sensitivity, than existing reagents (see also Gnerer et al., 2015) . As such, Trojan lines should serve as a new ''gold standard'' in determining the expression patterns of genes of interest. In addition, we have shown that Trojan lines can be readily generated for intersectional analysis to isolate previously inaccessible cell groups for characterization. Overall, the Trojan exon technology introduced here facilitates a range of cellular and genetic manipulations and allows them to be performed with unprecedented speed and accuracy. It does so by leveraging the largely unexploited capacity of coding introns to provide genetic access to specific cell types in vivo. Its implementation in other organisms using Crispr/ Cas-mediated genome editing (Seruggia and Montoliu, 2014) should be possible using strategies similar to the T-GEM technology introduced here.
EXPERIMENTAL PROCEDURES Molecular Biology Trojan Exon Constructs
All Trojan exons except the T-GEM construct were made by incorporating primary transgene coding sequences into the protein trap vectors introduced by Venken et al. (2011a) for all three reading frames (Drosophila Genomics Resource Center, clones #1297, 1305, and 1313; Indiana University). Transgene coding sequences were amplified by PCR from the following sources: pC-attB-bursa-mCD8-EGFP-T2A-Gal4 (Addgene #39463) for Gal4; pBPZpGAL4DBDUw (Addgene #26233) (Pfeiffer et al., 2010) and pBPp65ADZpUw (Addgene #26234) (Pfeiffer et al., 2010) for Gal4DBD and p65AD, respectively; pCAST-CCAP-dVP16ADZip-used to create pP {y+, dVP16AD} (Gao et al., 2008; Luan et al., 2006 )-for dVP16AD; pattbnsyb-QF2-Hsp70 (Addgene #46115) for QF2 (Riabinina et al., 2015) ; and pattb-nsyb-Lex::QF-Hsp70 (Addgene #46123) for LexA::QFAD. The T2A-Gal80 FLAG/HA -P2A-Gal80 EGFP -T2A-Gal80-Hsp70 sequence was synthesized by Epoch Life Science using the P2A and T2A sequences described in Diao and White (2012) and the Drosophilized Gal80 sequence of Pfeiffer et al. (2010) .
The pT-GEM vectors were assembled in pBlueScript from T2A-Gal4-Hsp70 sequences made as described above and a 3XP3 red fluorescent protein (RFP) selection marker (Bischof et al., 2007) with flanking inverted loxP sites synthesized by Epoch Life Science. To insert the T-GEM construct into the pburs locus, homology arms of approximately 1 kb were amplified by PCR from genomic DNA of the {nos-Cas9} attP2 transgenic fly line used for embryo microinjection (Ren et al., 2013) . The guide RNA expression construct (sgRNA) was made by inserting a DNA fragment, produced by annealing the oligonucleotides ttcgAGAGTTCGCTAACTCTATAG and aaacCTATAGAGTTAGCGAA CTCT, into the BbsI (New England Biolabs)-digested U6b-sgRNA-short plasmid of Ren et al. (2013) .
Triplet and Singlet Donor Constructs
The triplet donor construct was assembled from several synthesized gene fragments. The attB2 and SA sequences were from Venken et al. (2011a) ; the sequences of the loxP, loxN, and lox2272 sites were identical to those in Livet et al. (2007) ; the unique 100-bp spacer sequences separating each pair of lox and attB sites were derived from a 600-bp sequence in the promoter of nerfin1, which lacks DNA regulatory elements (Kuzin et al., 2009) ; the T2A-Gal4 sequence was the same as used for the Trojan Gal4 constructs. After synthesis, the fragments were assembled and cloned into pCAST (Luan et al., 2006) to make the final construct, pC-(lox2-attB2-SA-T2A-Gal4-Hsp70)3.
Singlet donor constructs were made similarly to the triplet donor constructs. First, backbone fragments consisting of loxP-flanked attB2-SA sequences were synthesized in all three phases and subcloned into the pCAST vector (Luan et al., 2006) to make the pC-(loxP2-attB2-SA). A T2A-Gal4-Hsp70 fragment derived from the Trojan Gal4 construct by BamH I digestion was then cloned into these vectors to make the pC-(loxP2-attB2-SA-T2A-Gal4-Hsp70) singlet donor constructs. TubP-dVP16AD, TubP-Gal4DBD, and ETH-Gal4 Constructs Constructs in which the dVP16ADZip and ZipGal4DBDflUw sequences described above were expressed under the tubulin-1a promoter (TubP) were made by replacing the Gal80 sequence in the pCaSpeR4-tubP-Gal80 vector (gift of Tzumin Lee). The ETH-Gal4 construct was made by cloning a 397-bp promoter fragment lying just upstream of the ETH start methionine into the pPTGAL vector (Sharma et al., 2002) . Fly Lines MiMIC lines were obtained from the Bloomington Stock Center at Indiana University or the Bellen Lab of Baylor College of Medicine. The TubP-dVP16AD, TubP-Gal4DBD, and ETH-Gal4 lines were made by P-element transformation, and the insertions of TubP-dVP16AD and TubP-Gal4DBD on chromosomes X, II, and III were isolated and characterized. An ETH-Gal4 insertion on chromosome II was used in the experiments described here. The following lines were described previously: w;+;Burs-Gal4DBD (Luan et al., 2012 ) and w;Sp/CyO; CCAP-Gal4DBD and yw;elav-Gal4DBD;Dr/TM3,Sb (Luan et al., 2006 Table S1 .
Lines Made by FC31-Mediated Conversion of MiMIC Lines by Plasmid Injection
Midiprep plasmid DNA containing the desired Trojan exon in the correct reading frame was injected together with FC31 plasmid DNA into the embryos of flies bearing MiMIC insertions in genes of interest. Recombinant transformants were isolated as described in Figure S1 , using UAS-2XEYFP, UAS-2XEGFP, 13XLexAop2-myr-tdTomato, and QUAS-mCD8-GFP as fluorescent expression markers. In some cases, developmental lethality was observed that appeared to derive from high levels of fluorescent protein expression. In these cases, G0 flies were crossed with flies from the yw;Sp/CyO;Dr/ TM3,Sb double balancer line, and y À recombinant progeny, which had lost the y + selection marker associated with the MiMIC insertion, were isolated.
The orientation of the Trojan exon insert was then determined by PCR amplification of the insertion. Since in general, the endogenous fluorescence of the EGFP-tagged Gal80 moiety was too weak to detect in live animals, this strategy was also used to screen for MiMIC-3XGal80 FLAG/HA/EGFP -Hsp70 flies. Lines Made In Vivo using the Triplet Donor Line Flies bearing inserts of the triplet donor transgene were made by P-elementmediated transformation using pC-(lox2-attB2-SA-T2A-Gal4-Hsp70)3. Lines were established with insertions of the triplet donor on chromosomes X, II, and III. A transgenic line with the second chromosome insert was used as the Trojan Gal4 donor to make the Trojan-MiMIC Gal4 lines as described in Figure S1 . Pburs TGEM -Gal4 Line Made using pT-GEM The Pburs TGEM -Gal4 transgenic flies were made by microinjecting into embryos of {nos-Cas9} attP2 flies (Ren et al., 2013 ) the sgRNA and pT-GEM plasmid DNA. The adults were screened by fluorescence for eye-specific expression of RFP. Immunostaining, Fluorescent In Situ Hybridization, and Confocal Microscopy Fixation, staining, and confocal imaging of whole-mount CNS preparations from third-instar larvae or adults were carried out as described previously (Luan et al., 2012) . Primary antibodies were used as described in the Supplemental Experimental Procedures and were the kind gifts of the following individuals: rabbit anti-VGlut (Aaron DiAntonio); guinea pig anti-Eve (Kosman et al., 1998 ) (Dr. John Reinitz); mouse anti-Pburs (Aaron Hsueh). The rabbit antiBursa and anti-CCAP antibodies were the same as in Luan et al. (2006) , and mouse anti-LacZ and mouse anti-EGFP were from Promega and Invitrogen, respectively. Alexa 488 and Alexa Fluor 568 and 647 secondary antibodies were from Invitrogen. Embryonic fluorescent in situ hybridization to confirm the fidelity of expression in the Cha MI04508 -Gal4 line used a riboprobe synthesized from the coding sequence of the VAChT gene, which is coexpressed from the same genomic locus as Cha (Kitamoto et al., 1998) . T7 RNA polymerase (New England Biolabs) was used to generate the riboprobe, and VAChT mRNA was visualized using a sheep anti-DIG-POD antibody (Roche). See the Supplemental Experimental Procedures for more details. Fluorescent imaging of larval and adult CNS preparations was performed with a Nikon C-1 confocal microscope using a 203 objective, and the images shown are composites of separately acquired volume-rendered images. A Leica TCS SP5 confocal microscope with a 633 oil-immersion objective was used for imaging late embryonic and early larval ventral nerve cords.
ACCESSION NUMBERS
The GenBank accession numbers for pC-(loxP2-attB2-SA(0)), pC-(loxP2-attB2-SA(1)), pC-(loxP2-attB2-SA(2)), pC-(lox2-attB2-SA-Hsp70)3, pT-GEM(0), pT-GEM(1), and pT-GEM(2) are KP686436, KP686437, KP686438, KP686439, KP686440, KP686441, and KP686442, respectively. 
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